Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Pharm Res. 2014 Jan 23;31(6):1605–1615. doi: 10.1007/s11095-013-1265-3

Figure 6.

Figure 6

Comparative effect of the CPVA-FLOX/17-AAG nanoformulation and free 17-AAG (2% DMSO solution) on the HSP70 expression in 4T1 cells.(A) Cell lysates analyzed by Western blot using HSC70 protein and β-actin as internal controls. (B) Normalized HSP70 levels obtained by Western blot densitometry. Shown data are means ± SEM (n = 3). NT: non-treated cells.